Xu K - Search Results

1

Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.

Sang W, Zhou C, Cheng N, Li Z, Zeng L, Xu K. Sang W, et al. Among authors: xu k. Immunol Lett. 2011 May;136(2):194-202. doi: 10.1016/j.imlet.2011.01.010. Epub 2011 Jan 26. Immunol Lett. 2011. PMID: 21277900

2

[Improvements of lentiviral vector and its application in gene therapy of hematological diseases].

Zhu HH, Xu KL. Zhu HH, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Apr;11(2):208-12. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 12744751 Review. Chinese.

3

[Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].

Xu KL, Ju JP, Pan XY, Du B, Li ZY, Lu QX. Xu KL, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Jul;24(7):372-5. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12941194 Chinese.

4

Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.

Du B, Li DP, Xu KL, Pan XY. Du B, et al. Chin Med J (Engl). 2005 Mar 20;118(6):474-9. Chin Med J (Engl). 2005. PMID: 15788128

5

Inhibiting the expression of CD28 costimulatory molecule on human lymphocytes by special siRNA.

Xu KL, Zhang Y, Pan XY, Lu QX. Xu KL, et al. Chin Med J (Engl). 2005 Mar 20;118(6):480-6. Chin Med J (Engl). 2005. PMID: 15788129

6

[In vitro killing effect of mutant thymidine kinase mediated by lentiviral vector on T lymphocytes].

Xu KL, Pan XY, Yang YJ, Lu QX, Li ZY, He XP. Xu KL, et al. Zhonghua Xue Ye Xue Za Zhi. 2005 Nov;26(11):678-81. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 16620557 Chinese.

7

[Expression of green fluorescent protein gene in mouse T lymphocytes mediated by lentiviral vector].

Li ZY, Xu KL, Pan XY, Sun HY, Gao F, Lu QX, Li DP, He XP. Li ZY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Feb;15(1):125-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17490537 Chinese.

8

Correlation of class II transactivator with HLA-DR antigen and its implications.

Xu KL, Li H, Pan XY, Li ZY, Lu QX, Zhang Y, Zhu HH, DU B, Zeng LY. Xu KL, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Feb;15(1):147-51. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17490542

9

[Study on control of graft-versus-host disease by blocking CD137-CD137L ligand costimulatory pathway in mice].

Li CH, Xu KL, Pan XY, Du B. Li CH, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Feb;28(2):93-7. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 17650668 Chinese.

10

Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.

Xu K, Li C, Pan X, Du B. Xu K, et al. Int J Hematol. 2007 Jul;86(1):84-90. doi: 10.1532/IJH97.A10613. Int J Hematol. 2007. PMID: 17675273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,666 results

Search Page

Filters